<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34243731</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case.</ArticleTitle><Pagination><StartPage>273</StartPage><MedlinePgn>273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-021-02306-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. Pathologically, it is characterized by eosinophilic hyaline intranuclear inclusions in the cells of the visceral organs as well as central, peripheral, and autonomic nervous system cells. Recently, a GGC repeat expansion in the NOTCH2NLC gene has been identified as the etiopathological agent of NIID. Interestingly, this GGC repeat expansion was also reported in some patients with a clinical diagnosis of amyotrophic lateral sclerosis (ALS). However, there are no autopsy-confirmed cases of concurrent NIID and ALS.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 60-year-old Taiwanese woman reported a four-month history of progressive weakness beginning in the right foot that spread to all four extremities. She was diagnosed with ALS because she met the revised El Escorial diagnostic criteria for definite ALS with upper and lower motor neuron involvement in the cervical, thoracic, and lumbosacral regions. She died of respiratory failure at 22&#xa0;months from ALS onset, at the age of 62&#xa0;years. Brain magnetic resonance imaging (MRI) revealed lesions in the medial part of the cerebellar hemisphere, right beside the vermis (paravermal lesions). The subclinical neuropathy, indicated by a nerve conduction study (NCS), prompted a potential diagnosis of NIID. Antemortem skin biopsy and autopsy confirmed the coexistence of pathology consistent with both ALS and NIID. We observed neither eccentric distribution of p62-positive intranuclear inclusions in the areas with abundant large motor neurons nor cytopathological coexistence of ALS and NIID pathology in motor neurons. This finding suggested that ALS and NIID developed independently in this patient.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We describe a case of concurrent NIID and ALS discovered during an autopsy. Abnormal brain MRI findings, including paravermal lesions, could indicate the coexistence of NIID even in patients with ALS showing characteristic clinical phenotypes.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sugiyama</LastName><ForeName>Atsuhiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0705-9892</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. asugiyama@chiba-u.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koide</LastName><ForeName>Mizuho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokota</LastName><ForeName>Hajime</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukai</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology, Chiba University Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitayama</LastName><ForeName>Yoshihisa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibuya</LastName><ForeName>Kazumoto</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araki</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isose</LastName><ForeName>Sagiri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Kimiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanaka</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Urayasu Rehabilitation Education Center, Chiba University Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Terunori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Kimihito</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwabara</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C537395">Neuronal intranuclear inclusion disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045586" MajorTopicYN="N">Intranuclear Inclusion Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Autopsy</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Neuronal intranuclear inclusion disease</Keyword><Keyword MajorTopicYN="N">Paravermal lesion</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest associated with this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>10</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34243731</ArticleId><ArticleId IdType="pmc">PMC8268606</ArticleId><ArticleId IdType="doi">10.1186/s12883-021-02306-5</ArticleId><ArticleId IdType="pii">10.1186/s12883-021-02306-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Takahashi-Fujigasaki J. Neuronal intranuclear hyaline inclusion disease. Neuropathology. 2003;23:351&#x2013;359. doi: 10.1046/j.1440-1789.2003.00524.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1789.2003.00524.x</ArticleId><ArticleId IdType="pubmed">14719553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, Araki K, Kato T, Nakamura T, Koike H, Takashima H, Hashiguchi A, Kohno Y, Kurashige T, Kuriyama M, Takiyama Y, Tsuchiya M, Kitagawa N, Kawamoto M, Yoshimura H, Suto Y, Nakayasu H, Uehara N, Sugiyama H, Takahashi M, Kokubun N, Konno T, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016;139:3170&#x2013;3186. doi: 10.1093/brain/aww249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww249</ArticleId><ArticleId IdType="pmc">PMC5382941</ArticleId><ArticleId IdType="pubmed">27797808</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, Koike H, Hashiguchi A, Takashima H, Sugiyama H, Kohno Y, Takiyama Y, Maeda K, Doi H, Koyano S, Takeuchi H, Kawamoto M, Kohara N, Ando T, Ieda T, Kita Y, Kokubun N, Tsuboi Y, Katoh K, Kino Y, Katsuno M, Iwasaki Y, Yoshida M, Tanaka F, Suzuki IK, Frith MC, Matsumoto N, Sobue G. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 2019;51:1215&#x2013;21. doi: 10.1038/s41588-019-0459-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0459-y</ArticleId><ArticleId IdType="pubmed">31332381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Wang JL, Huang W, Zeng S, Jiao B, Liu Z, Chen Z, Li Y, Wang Y, Min HX, Wang XJ, You Y, Zhang RX, Chen XY, Yi F, Zhou YF, Long HY, Zhou CJ, Hou X, Wang JP, Xie B, Liang F, Yang ZY, Sun QY, Allen EG, Shafik AM, Kong HE, Guo JF, Yan XX, Hu ZM, Xia K, Jiang H, Xu HW, Duan RH, Jin P, Tang BS, Shen L. Expansion of human-specific GGC repeat in neuronal intranuclear inclusion disease-related disorders. Am J Hum Genet. 2019;105:166&#x2013;176. doi: 10.1016/j.ajhg.2019.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2019.05.013</ArticleId><ArticleId IdType="pmc">PMC6612530</ArticleId><ArticleId IdType="pubmed">31178126</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Ichikawa Y, Mano T, Iwata A, Harigaya Y, Matsukawa MK, Matsukawa T, Tanaka M, Shirota Y, Ohtomo R, Kowa H, Date H, Mitsue A, Hatsuta H, Morimoto S, Murayama S, Shiio Y, Saito Y, Mitsutake A, Kawai M, Sasaki T, Sugiyama Y, Hamada M, Ohtomo G, Terao Y, Nakazato Y, Takeda A, Sakiyama Y, Umeda-Kameyama Y, Shinmi J, Ogata K, Kohno Y, Lim SY, Tan AH, Shimizu J, Goto J, Nishino I, Toda T, Morishita S, Tsuji S. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019;51:1222&#x2013;1232. doi: 10.1038/s41588-019-0347-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0347-5</ArticleId><ArticleId IdType="pubmed">31332380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun QY, Xu Q, Tian Y, Hu ZM, Qin LX, Yang JX, Huang W, Xue J, Li JC, Zeng S, Wang Y, Min HX, Chen XY, Wang JP, Xie B, Liang F, Zhang HN, Wang CY, Lei LF, Yan XX, Xu HW, Duan RH, Xia K, Liu JY, Jiang H, Shen L, Guo JF, Tang BS. Expansion of GGC repeat in the human-specific NOTCH2NLC gene is associated with essential tremor. Brain. 2020;143:222&#x2013;233. doi: 10.1093/brain/awz372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz372</ArticleId><ArticleId IdType="pubmed">31819945</ArticleId></ArticleIdList></Reference><Reference><Citation>Okubo M, Doi H, Fukai R, Fujita A, Mitsuhashi S, Hashiguchi S, Kishida H, Ueda N, Morihara K, Ogasawara A, Kawamoto Y, Takahashi T, Takahashi K, Nakamura H, Kunii M, Tada M, Katsumoto A, Fukuda H, Mizuguchi T, Miyatake S, Miyake N, Suzuki J, Ito Y, Sone J, Sobue G, Takeuchi H, Matsumoto N, Tanaka F. GGC repeat expansion of NOTCH2NLC in adult patients with leukoencephalopathy. Ann Neurol. 2019;86:962&#x2013;8. doi: 10.1002/ana.25586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25586</ArticleId><ArticleId IdType="pubmed">31433517</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Liu Z, Hou X, Li W, Ni J, Huang L, Hu Y, Liu P, Hou X, Xue J, Sun Q, Tian Y, Jiao B, Duan R, Jiang H, Shen L, Tang B, Wang J. Identification of GGC repeat expansion in the NOTCH2NLC gene in amyotrophic lateral sclerosis. Neurology. 2020;95:e3394&#x2013;e3405. doi: 10.1212/WNL.0000000000010945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010945</ArticleId><ArticleId IdType="pubmed">32989102</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisted: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;9. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Sato N, Kimura Y, Maekawa T, Enokizono M, Saito Y, Takahashi Y, Matsuda H, Kuwabara S. MR imaging features of the cerebellum in adult-onset neuronal intranuclear inclusion disease: 8 cases. Am J Neuroradiol. 2017;38:2100&#x2013;2104. doi: 10.3174/ajnr.A5336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5336</ArticleId><ArticleId IdType="pmc">PMC7963582</ArticleId><ArticleId IdType="pubmed">28818825</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura S, Takahashi M, Abe K, Inaba A, Sone J, Orimo J. A case of neuronal intranuclear inclusion disease with recurrent vomiting and without apparent DWI abnormality for the first seven years. Heliyon. 2020;6:e04675. doi: 10.1016/j.heliyon.2020.e04675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e04675</ArticleId><ArticleId IdType="pmc">PMC7424193</ArticleId><ArticleId IdType="pubmed">32817896</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Uchihara T, Mochizuki Y, Ishihara A, Nakamura A, Sasaki S, Uchiyama S, Iwata M, Mizutani T. Supranuclear ophthalmoparesis and vacuolar degeneration of the cerebral white matter in amyotrophic lateral sclerosis: a clinicopathological study. Amyotroph Lateral Scler. 2012;13:74&#x2013;83. doi: 10.3109/17482968.2011.603731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.603731</ArticleId><ArticleId IdType="pubmed">21861592</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone J, Hishikawa N, Koike H, Hattori N, Hirayama M, Nagamatsu M, Yamamoto M, Tanaka F, Yoshida M, Hashizume Y, Imamura H, Yamada E, Sobue G. Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy. Neurology. 2005;65:1538&#x2013;1543. doi: 10.1212/01.wnl.0000184490.22527.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000184490.22527.90</ArticleId><ArticleId IdType="pubmed">16301479</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:344&#x2013;352. doi: 10.1002/(SICI)1097-4598(200003)23:3&lt;344::AID-MUS5&gt;3.0.CO;2-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(200003)23:3&lt;344::AID-MUS5&gt;3.0.CO;2-N</ArticleId><ArticleId IdType="pubmed">10679710</ArticleId></ArticleIdList></Reference><Reference><Citation>Theys PA, Peeters E, Robberecht W. Evolution of motor and sensory deficits in amyotrophic lateral sclerosis setimated by neurophysiological techniques. J Neurol. 1999;246:438&#x2013;442. doi: 10.1007/s004150050379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050379</ArticleId><ArticleId IdType="pubmed">10431767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology. 2007;69:2236&#x2013;2242. doi: 10.1212/01.wnl.0000286948.99150.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000286948.99150.16</ArticleId><ArticleId IdType="pubmed">18071143</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M, Johnsen B, Fawcett PR, Labarre-Vila A, Liguori R, Nix WA, Schofield IS. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry. 2007;78:746&#x2013;749. doi: 10.1136/jnnp.2006.098533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.098533</ArticleId><ArticleId IdType="pmc">PMC2117695</ArticleId><ArticleId IdType="pubmed">17575020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E, Botta-Orfila T, Bodi L, Marti S, Kovacs G, Grau-Rivera O, Lozano M, S&#xe1;nchez-Valle R, Mu&#xf1;oz E, Valldeoriola F, Pagonabarraga J, Tartaglia GG, Mil&#xe0; M. Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morophological and molecular dilemma. Brain. 2017;140:e51. doi: 10.1093/brain/awx156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx156</ArticleId><ArticleId IdType="pubmed">28899011</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilha IG, Nunes RH, Scortegagna FA, Pedroso JL, Marussi VH, Rodrigues Gon&#xe7;alves MR, Barsottini OGP, da Rocha AJ. MR imaging features of adult-onset neuronal intranuclear inclusion disease may be indistinguishable from fragile X-associated tremor/ataxia syndrome. Am J Neuroradiol. 2018;39:E100&#x2013;E101. doi: 10.3174/ajnr.A5729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5729</ArticleId><ArticleId IdType="pmc">PMC7655280</ArticleId><ArticleId IdType="pubmed">30072371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone J, Nakamura T, Koike H, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G. Reply: Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma. Brain. 2017;140:e52. doi: 10.1093/brain/awx158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx158</ArticleId><ArticleId IdType="pubmed">28899012</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS) Brain. 2006;129:243&#x2013;255. doi: 10.1093/brain/awh683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh683</ArticleId><ArticleId IdType="pubmed">16332642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M, Watanabe H, Sobue G. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology. 2011;76:1372&#x2013;1376. doi: 10.1212/WNL.0b013e3182166e13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182166e13</ArticleId><ArticleId IdType="pubmed">21411744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H, Iwasaki Y, Yoshida M, Takahashi T, Chiba S, Katsuno M, Tanaka F, Sobue G. Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry. 2014;85:354&#x2013;356. doi: 10.1136/jnnp-2013-306084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306084</ArticleId><ArticleId IdType="pubmed">24039026</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>